 | • レポートコード：QYR2104Z3761 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、マイクロバイオームのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（消化管マイクロバイオーム、泌尿生殖器マイクロバイオーム、皮膚マイクロバイオーム、呼吸器マイクロバイオーム、その他）、用途別市場規模（検査、治療、診断、テクノロジープラットフォーム、プロバイオティクス、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・マイクロバイオームの市場動向 ・企業の競争状況、市場シェア ・マイクロバイオームの種類別市場規模（消化管マイクロバイオーム、泌尿生殖器マイクロバイオーム、皮膚マイクロバイオーム、呼吸器マイクロバイオーム、その他） ・マイクロバイオームの用途別市場規模（検査、治療、診断、テクノロジープラットフォーム、プロバイオティクス、その他） ・マイクロバイオームの北米市場規模2016-2027（アメリカ、カナダ） ・マイクロバイオームのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・マイクロバイオームのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・マイクロバイオームの中南米市場規模2016-2027（メキシコ、ブラジル） ・マイクロバイオームの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（4D Pharma、Enterome BioScience、Evelo Biosciences、Ferring、Osel、Second Genome、Seres Therapeutics、Synlogic、Synthetic Biologics and Vedanta Biosciences、Vedanta、Rebiotix、ActoGeniX、Enterologics、Metabogen、Metabiomics、Ritter Pharmaceuticals、AvidBiotics、Symberix、Miomics、Symbiotix Biotherapies、MicroBiome Therapeutics LLC、SciBac Inc） ・結論 |
Market Analysis and Insights: Global Microbiomes Market
The global Microbiomes market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Microbiomes market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Microbiomes market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Microbiomes market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Microbiomes market.
Global Microbiomes Scope and Market Size
Microbiomes market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Microbiomes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Gastrointestinal Microbiome
Genitourinary Microbiome
Skin Microbiome
Respiratory Microbiome
Other
Segment by Application
Testing
Treatment
Diagnosis
Technology Platform
Probiotics
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
4D Pharma
Enterome BioScience
Evelo Biosciences
Ferring
Osel
Second Genome
Seres Therapeutics
Synlogic
Synthetic Biologics and Vedanta Biosciences
Vedanta
Rebiotix
ActoGeniX
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
AvidBiotics
Symberix
Miomics
Symbiotix Biotherapies
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microbiomes Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Gastrointestinal Microbiome
1.2.3 Genitourinary Microbiome
1.2.4 Skin Microbiome
1.2.5 Respiratory Microbiome
1.2.6 Other
1.3 Market by Application
1.3.1 Global Microbiomes Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Testing
1.3.3 Treatment
1.3.4 Diagnosis
1.3.5 Technology Platform
1.3.6 Probiotics
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Microbiomes Market Perspective (2016-2027)
2.2 Microbiomes Growth Trends by Regions
2.2.1 Microbiomes Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Microbiomes Historic Market Share by Regions (2016-2021)
2.2.3 Microbiomes Forecasted Market Size by Regions (2022-2027)
2.3 Microbiomes Industry Dynamic
2.3.1 Microbiomes Market Trends
2.3.2 Microbiomes Market Drivers
2.3.3 Microbiomes Market Challenges
2.3.4 Microbiomes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microbiomes Players by Revenue
3.1.1 Global Top Microbiomes Players by Revenue (2016-2021)
3.1.2 Global Microbiomes Revenue Market Share by Players (2016-2021)
3.2 Global Microbiomes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Microbiomes Revenue
3.4 Global Microbiomes Market Concentration Ratio
3.4.1 Global Microbiomes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbiomes Revenue in 2020
3.5 Microbiomes Key Players Head office and Area Served
3.6 Key Players Microbiomes Product Solution and Service
3.7 Date of Enter into Microbiomes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Microbiomes Breakdown Data by Type
4.1 Global Microbiomes Historic Market Size by Type (2016-2021)
4.2 Global Microbiomes Forecasted Market Size by Type (2022-2027)
5 Microbiomes Breakdown Data by Application
5.1 Global Microbiomes Historic Market Size by Application (2016-2021)
5.2 Global Microbiomes Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Microbiomes Market Size (2016-2027)
6.2 North America Microbiomes Market Size by Type
6.2.1 North America Microbiomes Market Size by Type (2016-2021)
6.2.2 North America Microbiomes Market Size by Type (2022-2027)
6.2.3 North America Microbiomes Market Size by Type (2016-2027)
6.3 North America Microbiomes Market Size by Application
6.3.1 North America Microbiomes Market Size by Application (2016-2021)
6.3.2 North America Microbiomes Market Size by Application (2022-2027)
6.3.3 North America Microbiomes Market Size by Application (2016-2027)
6.4 North America Microbiomes Market Size by Country
6.4.1 North America Microbiomes Market Size by Country (2016-2021)
6.4.2 North America Microbiomes Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Microbiomes Market Size (2016-2027)
7.2 Europe Microbiomes Market Size by Type
7.2.1 Europe Microbiomes Market Size by Type (2016-2021)
7.2.2 Europe Microbiomes Market Size by Type (2022-2027)
7.2.3 Europe Microbiomes Market Size by Type (2016-2027)
7.3 Europe Microbiomes Market Size by Application
7.3.1 Europe Microbiomes Market Size by Application (2016-2021)
7.3.2 Europe Microbiomes Market Size by Application (2022-2027)
7.3.3 Europe Microbiomes Market Size by Application (2016-2027)
7.4 Europe Microbiomes Market Size by Country
7.4.1 Europe Microbiomes Market Size by Country (2016-2021)
7.4.2 Europe Microbiomes Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Microbiomes Market Size (2016-2027)
8.2 Asia-Pacific Microbiomes Market Size by Type
8.2.1 Asia-Pacific Microbiomes Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Microbiomes Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Microbiomes Market Size by Type (2016-2027)
8.3 Asia-Pacific Microbiomes Market Size by Application
8.3.1 Asia-Pacific Microbiomes Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Microbiomes Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Microbiomes Market Size by Application (2016-2027)
8.4 Asia-Pacific Microbiomes Market Size by Region
8.4.1 Asia-Pacific Microbiomes Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Microbiomes Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Microbiomes Market Size (2016-2027)
9.2 Latin America Microbiomes Market Size by Type
9.2.1 Latin America Microbiomes Market Size by Type (2016-2021)
9.2.2 Latin America Microbiomes Market Size by Type (2022-2027)
9.2.3 Latin America Microbiomes Market Size by Type (2016-2027)
9.3 Latin America Microbiomes Market Size by Application
9.3.1 Latin America Microbiomes Market Size by Application (2016-2021)
9.3.2 Latin America Microbiomes Market Size by Application (2022-2027)
9.3.3 Latin America Microbiomes Market Size by Application (2016-2027)
9.4 Latin America Microbiomes Market Size by Country
9.4.1 Latin America Microbiomes Market Size by Country (2016-2021)
9.4.2 Latin America Microbiomes Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microbiomes Market Size (2016-2027)
10.2 Middle East & Africa Microbiomes Market Size by Type
10.2.1 Middle East & Africa Microbiomes Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Microbiomes Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Microbiomes Market Size by Type (2016-2027)
10.3 Middle East & Africa Microbiomes Market Size by Application
10.3.1 Middle East & Africa Microbiomes Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Microbiomes Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Microbiomes Market Size by Application (2016-2027)
10.4 Middle East & Africa Microbiomes Market Size by Country
10.4.1 Middle East & Africa Microbiomes Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Microbiomes Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 4D Pharma
11.1.1 4D Pharma Company Details
11.1.2 4D Pharma Business Overview
11.1.3 4D Pharma Microbiomes Introduction
11.1.4 4D Pharma Revenue in Microbiomes Business (2016-2021)
11.1.5 4D Pharma Recent Development
11.2 Enterome BioScience
11.2.1 Enterome BioScience Company Details
11.2.2 Enterome BioScience Business Overview
11.2.3 Enterome BioScience Microbiomes Introduction
11.2.4 Enterome BioScience Revenue in Microbiomes Business (2016-2021)
11.2.5 Enterome BioScience Recent Development
11.3 Evelo Biosciences
11.3.1 Evelo Biosciences Company Details
11.3.2 Evelo Biosciences Business Overview
11.3.3 Evelo Biosciences Microbiomes Introduction
11.3.4 Evelo Biosciences Revenue in Microbiomes Business (2016-2021)
11.3.5 Evelo Biosciences Recent Development
11.4 Ferring
11.4.1 Ferring Company Details
11.4.2 Ferring Business Overview
11.4.3 Ferring Microbiomes Introduction
11.4.4 Ferring Revenue in Microbiomes Business (2016-2021)
11.4.5 Ferring Recent Development
11.5 Osel
11.5.1 Osel Company Details
11.5.2 Osel Business Overview
11.5.3 Osel Microbiomes Introduction
11.5.4 Osel Revenue in Microbiomes Business (2016-2021)
11.5.5 Osel Recent Development
11.6 Second Genome
11.6.1 Second Genome Company Details
11.6.2 Second Genome Business Overview
11.6.3 Second Genome Microbiomes Introduction
11.6.4 Second Genome Revenue in Microbiomes Business (2016-2021)
11.6.5 Second Genome Recent Development
11.7 Seres Therapeutics
11.7.1 Seres Therapeutics Company Details
11.7.2 Seres Therapeutics Business Overview
11.7.3 Seres Therapeutics Microbiomes Introduction
11.7.4 Seres Therapeutics Revenue in Microbiomes Business (2016-2021)
11.7.5 Seres Therapeutics Recent Development
11.8 Synlogic
11.8.1 Synlogic Company Details
11.8.2 Synlogic Business Overview
11.8.3 Synlogic Microbiomes Introduction
11.8.4 Synlogic Revenue in Microbiomes Business (2016-2021)
11.8.5 Synlogic Recent Development
11.9 Synthetic Biologics and Vedanta Biosciences
11.9.1 Synthetic Biologics and Vedanta Biosciences Company Details
11.9.2 Synthetic Biologics and Vedanta Biosciences Business Overview
11.9.3 Synthetic Biologics and Vedanta Biosciences Microbiomes Introduction
11.9.4 Synthetic Biologics and Vedanta Biosciences Revenue in Microbiomes Business (2016-2021)
11.9.5 Synthetic Biologics and Vedanta Biosciences Recent Development
11.10 Vedanta
11.10.1 Vedanta Company Details
11.10.2 Vedanta Business Overview
11.10.3 Vedanta Microbiomes Introduction
11.10.4 Vedanta Revenue in Microbiomes Business (2016-2021)
11.10.5 Vedanta Recent Development
11.11 Rebiotix
11.11.1 Rebiotix Company Details
11.11.2 Rebiotix Business Overview
11.11.3 Rebiotix Microbiomes Introduction
11.11.4 Rebiotix Revenue in Microbiomes Business (2016-2021)
11.11.5 Rebiotix Recent Development
11.12 ActoGeniX
11.12.1 ActoGeniX Company Details
11.12.2 ActoGeniX Business Overview
11.12.3 ActoGeniX Microbiomes Introduction
11.12.4 ActoGeniX Revenue in Microbiomes Business (2016-2021)
11.12.5 ActoGeniX Recent Development
11.13 Enterologics
11.13.1 Enterologics Company Details
11.13.2 Enterologics Business Overview
11.13.3 Enterologics Microbiomes Introduction
11.13.4 Enterologics Revenue in Microbiomes Business (2016-2021)
11.13.5 Enterologics Recent Development
11.14 Metabogen
11.14.1 Metabogen Company Details
11.14.2 Metabogen Business Overview
11.14.3 Metabogen Microbiomes Introduction
11.14.4 Metabogen Revenue in Microbiomes Business (2016-2021)
11.14.5 Metabogen Recent Development
11.15 Metabiomics
11.15.1 Metabiomics Company Details
11.15.2 Metabiomics Business Overview
11.15.3 Metabiomics Microbiomes Introduction
11.15.4 Metabiomics Revenue in Microbiomes Business (2016-2021)
11.15.5 Metabiomics Recent Development
11.16 Ritter Pharmaceuticals
11.16.1 Ritter Pharmaceuticals Company Details
11.16.2 Ritter Pharmaceuticals Business Overview
11.16.3 Ritter Pharmaceuticals Microbiomes Introduction
11.16.4 Ritter Pharmaceuticals Revenue in Microbiomes Business (2016-2021)
11.16.5 Ritter Pharmaceuticals Recent Development
11.17 AvidBiotics
11.17.1 AvidBiotics Company Details
11.17.2 AvidBiotics Business Overview
11.17.3 AvidBiotics Microbiomes Introduction
11.17.4 AvidBiotics Revenue in Microbiomes Business (2016-2021)
11.17.5 AvidBiotics Recent Development
11.18 Symberix
11.18.1 Symberix Company Details
11.18.2 Symberix Business Overview
11.18.3 Symberix Microbiomes Introduction
11.18.4 Symberix Revenue in Microbiomes Business (2016-2021)
11.18.5 Symberix Recent Development
11.18 Miomics
.1 Miomics Company Details
.2 Miomics Business Overview
.3 Miomics Microbiomes Introduction
.4 Miomics Revenue in Microbiomes Business (2016-2021)
.5 Miomics Recent Development
11.20 Symbiotix Biotherapies
11.20.1 Symbiotix Biotherapies Company Details
11.20.2 Symbiotix Biotherapies Business Overview
11.20.3 Symbiotix Biotherapies Microbiomes Introduction
11.20.4 Symbiotix Biotherapies Revenue in Microbiomes Business (2016-2021)
11.20.5 Symbiotix Biotherapies Recent Development
11.21 MicroBiome Therapeutics LLC
11.21.1 MicroBiome Therapeutics LLC Company Details
11.21.2 MicroBiome Therapeutics LLC Business Overview
11.21.3 MicroBiome Therapeutics LLC Microbiomes Introduction
11.21.4 MicroBiome Therapeutics LLC Revenue in Microbiomes Business (2016-2021)
11.21.5 MicroBiome Therapeutics LLC Recent Development
11.22 SciBac Inc
11.22.1 SciBac Inc Company Details
11.22.2 SciBac Inc Business Overview
11.22.3 SciBac Inc Microbiomes Introduction
11.22.4 SciBac Inc Revenue in Microbiomes Business (2016-2021)
11.22.5 SciBac Inc Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Microbiomes Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Gastrointestinal Microbiome
Table 3. Key Players of Genitourinary Microbiome
Table 4. Key Players of Skin Microbiome
Table 5. Key Players of Respiratory Microbiome
Table 6. Key Players of Other
Table 7. Global Microbiomes Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Microbiomes Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Microbiomes Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Microbiomes Market Share by Regions (2016-2021)
Table 11. Global Microbiomes Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Microbiomes Market Share by Regions (2022-2027)
Table 13. Microbiomes Market Trends
Table 14. Microbiomes Market Drivers
Table 15. Microbiomes Market Challenges
Table 16. Microbiomes Market Restraints
Table 17. Global Microbiomes Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Microbiomes Market Share by Players (2016-2021)
Table 19. Global Top Microbiomes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microbiomes as of 2020)
Table 20. Ranking of Global Top Microbiomes Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Microbiomes Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Microbiomes Product Solution and Service
Table 24. Date of Enter into Microbiomes Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Microbiomes Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Microbiomes Revenue Market Share by Type (2016-2021)
Table 28. Global Microbiomes Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Microbiomes Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Microbiomes Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Microbiomes Revenue Market Share by Application (2016-2021)
Table 32. Global Microbiomes Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Microbiomes Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Microbiomes Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Microbiomes Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Microbiomes Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Microbiomes Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Microbiomes Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Microbiomes Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Microbiomes Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Microbiomes Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Microbiomes Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Microbiomes Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Microbiomes Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Microbiomes Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Microbiomes Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Microbiomes Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Microbiomes Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Microbiomes Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Microbiomes Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Microbiomes Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Microbiomes Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Microbiomes Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Microbiomes Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Microbiomes Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Microbiomes Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Microbiomes Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Microbiomes Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Microbiomes Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Microbiomes Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Microbiomes Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Microbiomes Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Microbiomes Market Size by Country (2022-2027) & (US$ Million)
Table 64. 4D Pharma Company Details
Table 65. 4D Pharma Business Overview
Table 66. 4D Pharma Microbiomes Product
Table 67. 4D Pharma Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 68. 4D Pharma Recent Development
Table 69. Enterome BioScience Company Details
Table 70. Enterome BioScience Business Overview
Table 71. Enterome BioScience Microbiomes Product
Table 72. Enterome BioScience Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 73. Enterome BioScience Recent Development
Table 74. Evelo Biosciences Company Details
Table 75. Evelo Biosciences Business Overview
Table 76. Evelo Biosciences Microbiomes Product
Table 77. Evelo Biosciences Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 78. Evelo Biosciences Recent Development
Table 79. Ferring Company Details
Table 80. Ferring Business Overview
Table 81. Ferring Microbiomes Product
Table 82. Ferring Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 83. Ferring Recent Development
Table 84. Osel Company Details
Table 85. Osel Business Overview
Table 86. Osel Microbiomes Product
Table 87. Osel Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 88. Osel Recent Development
Table 89. Second Genome Company Details
Table 90. Second Genome Business Overview
Table 91. Second Genome Microbiomes Product
Table 92. Second Genome Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 93. Second Genome Recent Development
Table 94. Seres Therapeutics Company Details
Table 95. Seres Therapeutics Business Overview
Table 96. Seres Therapeutics Microbiomes Product
Table 97. Seres Therapeutics Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 98. Seres Therapeutics Recent Development
Table 99. Synlogic Company Details
Table 100. Synlogic Business Overview
Table 101. Synlogic Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 102. Synlogic Recent Development
Table 103. Synthetic Biologics and Vedanta Biosciences Company Details
Table 104. Synthetic Biologics and Vedanta Biosciences Business Overview
Table 105. Synthetic Biologics and Vedanta Biosciences Microbiomes Product
Table 106. Synthetic Biologics and Vedanta Biosciences Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 107. Synthetic Biologics and Vedanta Biosciences Recent Development
Table 108. Vedanta Company Details
Table 109. Vedanta Business Overview
Table 110. Vedanta Microbiomes Product
Table 111. Vedanta Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 112. Vedanta Recent Development
Table 113. Rebiotix Company Details
Table 114. Rebiotix Business Overview
Table 115. Rebiotix Microbiomes Product
Table 116. Rebiotix Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 117. Rebiotix Recent Development
Table 118. ActoGeniX Company Details
Table 119. ActoGeniX Business Overview
Table 120. ActoGeniX Microbiomes Product
Table 121. ActoGeniX Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 122. ActoGeniX Recent Development
Table 123. Enterologics Company Details
Table 124. Enterologics Business Overview
Table 125. Enterologics Microbiomes Product
Table 126. Enterologics Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 127. Enterologics Recent Development
Table 128. Metabogen Company Details
Table 129. Metabogen Business Overview
Table 130. Metabogen Microbiomes Product
Table 131. Metabogen Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 132. Metabogen Recent Development
Table 133. Metabiomics Company Details
Table 134. Metabiomics Business Overview
Table 135. Metabiomics Microbiomes Product
Table 136. Metabiomics Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 137. Metabiomics Recent Development
Table 138. Ritter Pharmaceuticals Company Details
Table 139. Ritter Pharmaceuticals Business Overview
Table 140. Ritter Pharmaceuticals Microbiomes Product
Table 141. Ritter Pharmaceuticals Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 142. Ritter Pharmaceuticals Recent Development
Table 143. AvidBiotics Company Details
Table 144. AvidBiotics Business Overview
Table 145. AvidBiotics Microbiomes Product
Table 146. AvidBiotics Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 147. AvidBiotics Recent Development
Table 148. Symberix Company Details
Table 149. Symberix Business Overview
Table 150. Symberix Microbiomes Product
Table 151. Symberix Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 152. Symberix Recent Development
Table 153. Miomics Company Details
Table 154. Miomics Business Overview
Table 155. Miomics Microbiomes Product
Table 156. Miomics Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 157. Miomics Recent Development
Table 158. Symbiotix Biotherapies Company Details
Table 159. Symbiotix Biotherapies Business Overview
Table 160. Symbiotix Biotherapies Microbiomes Product
Table 161. Symbiotix Biotherapies Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 162. Symbiotix Biotherapies Recent Development
Table 163. MicroBiome Therapeutics LLC Company Details
Table 164. MicroBiome Therapeutics LLC Business Overview
Table 165. MicroBiome Therapeutics LLC Microbiomes Product
Table 166. MicroBiome Therapeutics LLC Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 167. MicroBiome Therapeutics LLC Recent Development
Table 168. SciBac Inc Company Details
Table 169. SciBac Inc Business Overview
Table 170. SciBac Inc Microbiomes Product
Table 171. SciBac Inc Revenue in Microbiomes Business (2016-2021) & (US$ Million)
Table 172. SciBac Inc Recent Development
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Microbiomes Market Share by Type: 2020 VS 2027
Figure 2. Gastrointestinal Microbiome Features
Figure 3. Genitourinary Microbiome Features
Figure 4. Skin Microbiome Features
Figure 5. Respiratory Microbiome Features
Figure 6. Other Features
Figure 7. Global Microbiomes Market Share by Application: 2020 VS 2027
Figure 8. Testing Case Studies
Figure 9. Treatment Case Studies
Figure 10. Diagnosis Case Studies
Figure 11. Technology Platform Case Studies
Figure 12. Probiotics Case Studies
Figure 13. Other Case Studies
Figure 14. Microbiomes Report Years Considered
Figure 15. Global Microbiomes Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Microbiomes Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Microbiomes Market Share by Regions: 2020 VS 2027
Figure 18. Global Microbiomes Market Share by Regions (2022-2027)
Figure 19. Global Microbiomes Market Share by Players in 2020
Figure 20. Global Top Microbiomes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microbiomes as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Microbiomes Revenue in 2020
Figure 22. Global Microbiomes Revenue Market Share by Type (2016-2021)
Figure 23. Global Microbiomes Revenue Market Share by Type (2022-2027)
Figure 24. North America Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Microbiomes Market Share by Type (2016-2027)
Figure 26. North America Microbiomes Market Share by Application (2016-2027)
Figure 27. North America Microbiomes Market Share by Country (2016-2027)
Figure 28. United States Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Microbiomes Market Share by Type (2016-2027)
Figure 32. Europe Microbiomes Market Share by Application (2016-2027)
Figure 33. Europe Microbiomes Market Share by Country (2016-2027)
Figure 34. Germany Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Microbiomes Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Microbiomes Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Microbiomes Market Share by Region (2016-2027)
Figure 44. China Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Microbiomes Market Share by Type (2016-2027)
Figure 52. Latin America Microbiomes Market Share by Application (2016-2027)
Figure 53. Latin America Microbiomes Market Share by Country (2016-2027)
Figure 54. Mexico Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Microbiomes Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Microbiomes Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Microbiomes Market Share by Country (2016-2027)
Figure 60. Turkey Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Microbiomes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. 4D Pharma Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 64. Enterome BioScience Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 65. Evelo Biosciences Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 66. Ferring Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 67. Osel Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 68. Second Genome Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 69. Seres Therapeutics Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 70. Synlogic Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 71. Synthetic Biologics and Vedanta Biosciences Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 72. Vedanta Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 73. Rebiotix Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 74. ActoGeniX Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 75. Enterologics Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 76. Metabogen Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 77. Metabiomics Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 78. Ritter Pharmaceuticals Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 79. AvidBiotics Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 80. Symberix Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 81. Miomics Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 82. Symbiotix Biotherapies Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 83. MicroBiome Therapeutics LLC Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 84. SciBac Inc Revenue Growth Rate in Microbiomes Business (2016-2021)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
世界のマイクロバイオーム医薬品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Microbiome Drugs Market The global Microbiome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a b…- 世界のヒトマイクロバイオーム市場規模・現状・予測（2021年-2027年） The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a to…
- 世界のヒトマイクロバイオーム治療市場規模・現状・予測（2021年-2027年） Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of the fastest growing areas of biology, and is considered as a newly discovered organ with the potential to have a tremendous impact on human health. Mic…
- 世界のマイクロバイオームシーケンスサービス市場規模・現状・予測（2021年-2027年） The rising use of microbiomes in genomics, proteomics, and metabolomics and technological advancements in next-generation sequencing (NGS) are the major factors driving the growth of the global microbiome sequencing services. The pharmaceutical and biotechnology companies segment is expected to grow…
- 世界のマイクロバイオームシーケンスサービス市場規模・現状・予測（2021年-2027年） The rising use of microbiomes in genomics, proteomics, and metabolomics and technological advancements in next-generation sequencing (NGS) are the major factors driving the growth of the global microbiome sequencing services. The pharmaceutical and biotechnology companies segment is expected to grow…